Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Tryptyr (acoltremon) Ophthalmic Solution for the Treatment of Dry Eye Disease

(BUSINESS WIRE) May 28, 2025 -- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S....

US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon Hadlima (adalimumab-bwwd) Injection

(BUSINESS WIRE) May 27, 2025 -- Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE: OGN) today announced that the US Food and Drug Administration (FDA)...

FDA Approves Starjemza (ustekinumab-hmny), a Biosimilar to Stelara

Guangzhou and London – May 27, 2025 – Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing...

FDA Approves Yutrepia (treprostinil) Inhalation Powder for Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced...

FDA Approves Brekiya (dihydroergotamine mesylate) Injection for the Acute Treatment of Migraine and Cluster Headaches in Adults

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration...

Race, Ethnicity Influence Sodium Sources, Sodium Reduction Behavior

There are similarities and differences in the sources of sodium and sodium reduction behaviors between racial and ethnic groups, according to a study published...

American College of Obstetricians and Gynecologists, May 16-18

The annual meeting of the American College of Obstetricians and Gynecologists (ACOG) was held from May 16 to 18 in Minneapolis and was attended...

Parts of the World Seeing New COVID-19 Variant

Health officials at the World Health Organization are warning of a rise in cases from a new COVID-19 variant.The new variant, NB.1.8.1, has been spotted...

High-Volume Exercise Tied to Increased Coronary Artery Calcification Score

Male athletes with high-volume exercise training have a higher burden of calcified plaque than male nonathletes, according to a review published in the...

Odds of Cardiovascular Events Up for RSV Hospitalization Versus COVID-19 Hospitalization

Patients with respiratory syncytial virus (RSV) hospitalization have increased odds of any acute cardiovascular event compared with COVID-19 hospitalizations,...

Shedding Pounds in Middle Age Could Add Years to Your Life, Study Finds

WEDNESDAY, May 28, 2025 — Losing just 6.5% of body weight in midlife may lower later risk of disease and premature death, new research shows. Researchers...

RFK Jr. Ends COVID Vaccine Urging for Healthy Kids, Pregnant Women

WEDNESDAY, May 28, 2025 — The top U.S. health agency will no longer recommend the COVID-19 vaccine for healthy children and pregnant women. Tuesday's...

Miley Cyrus Reveals Rare Condition That Shapes Her Signature Voice

WEDNESDAY, May 28, 2025 — Singer and actress Miley Cyrus says a rare voice disorder called Reinke’s edema is behind her famous raspy voice...

Phase 3 Clinical Study of Mazdutide in Chinese Adults with Overweight or Obesity (GLORY-1) Published in The New England Journal of Medicine (NEJM)

SAN FRANCISCO, U.S., SUZHOU, China May 26, 2025 – Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical...

Drug Safety Communication - FDA Warns About Risk of Severe Itching After Discontinuation of Long-Term Use of Allergy Medicines Cetirizine or Levocetirizine

 The FDA is warning that patients stopping the oral allergy medicines cetirizine (Zyrtec) or levocetirizine (Xyzal) after long-term use may experience...

Prothena Announces Phase 3 AFFIRM-AL Clinical Trial for Birtamimab in Patients with AL Amyloidosis Did Not Meet Primary Endpoint

(BUSINESS WIRE) May 23, 2025 --Prothena Corporation plc (NASDAQ:PRTA) today announced the Phase 3 AFFIRM-AL clinical trial evaluating birtamimab in patients...

FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines

THURSDAY, May 22, 2025 — The U.S. Food and Drug Administration (FDA) has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines. The...

Read more news...

Recently Added

Recently added consumer and prescribing information: Miudella, Opdivo Qvantig, Alyftrek, Crenessity, Ensacove, Steqeyma, Yesintek, Revuforj, Danziten, Aucatzyl

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Tryptyr Tryptyr (acoltremon) is a first-in-class TRPM8 thermoreceptor agonist indicated for the treatment of the signs and symptoms of dry eye disease.
  • Starjemza Starjemza (ustekinumab-hmny) is a human interleukin-12 and -23 antagonist biosimilar to Stelara used for the treatment of plaque psoriasis...
  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of the prostacyclin mimetic treprostinil approved for the treatment of...

More FDA approvals